Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Bloom

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
BMJ Open|October 3, 2022
METRIC-EF: magnetic resonance enterography to predict disabling disease in newly diagnosed Crohn's disease-protocol for a multicentre, non-randomised, single-arm, prospective studyShankar Kumar, Andrew Plumb, Sue Mallett, et al.
Gut|April 6, 2011
Guidelines for the management of inflammatory bowel disease in adultsCraig Mowat, Andrew Cole, Al Windsor, et al.
Radiology|July 29, 2009
Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging featuresShonit Punwani, Manuel Rodriguez-Justo, Alan Bainbridge, et al.
Journal of Crohn'S & Colitis|May 22, 2016
Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative ColitisRaja Atreya, Stuart Bloom, Franco Scaldaferri, et al.
Frontline Gastroenterology|August 26, 2017
Disease status, patient quality of life and healthcare resource use for ulcerative colitis in the UK: an observational studyCarolynne J Vaizey, Peter R Gibson, Christopher M Black, et al.
Frontline Gastroenterology|August 15, 2023
Establishing key performance indicators for inflammatory bowel disease in the UKMohammed Nabil Quraishi, Elizabeth Dobson, Rachel Ainley, et al.
Therapeutic Advances in Chronic Disease|August 21, 2023
Two-year real-world outcome data from a single tertiary centre shows reduced ustekinumab persistence in a non-bio-naïve Crohn's disease cohort with penetrating disease, -ostomies and sarcopeniaSaskia Inniss, Konstantinos C Fragkos, Lisa Whitley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2018
Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103)Kathy D Miller, Anne O'Neill, William Gradishar, et al.
BMC Gastroenterology|August 12, 2014
METRIC (MREnterography or ulTRasound in Crohn's disease): a study protocol for a multicentre, non-randomised, single-arm, prospective comparison study of magnetic resonance enterography and small bowel ultrasound compared to a reference standard in those aged 16 and overStuart Taylor, Susan Mallett, Gauraang Bhatnagar, et al.
Gastrointestinal Endoscopy|April 17, 2018
Reliability among central readers in the evaluation of endoscopic disease activity in pouchitisMark A Samaan, Bo Shen, Mahmoud H Mosli, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
BMJ Open|October 3, 2022
METRIC-EF: magnetic resonance enterography to predict disabling disease in newly diagnosed Crohn's disease-protocol for a multicentre, non-randomised, single-arm, prospective studyShankar Kumar, Andrew Plumb, Sue Mallett, et al.
Gut|April 6, 2011
Guidelines for the management of inflammatory bowel disease in adultsCraig Mowat, Andrew Cole, Al Windsor, et al.
Radiology|July 29, 2009
Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging featuresShonit Punwani, Manuel Rodriguez-Justo, Alan Bainbridge, et al.
Journal of Crohn'S & Colitis|May 22, 2016
Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative ColitisRaja Atreya, Stuart Bloom, Franco Scaldaferri, et al.
Frontline Gastroenterology|August 26, 2017
Disease status, patient quality of life and healthcare resource use for ulcerative colitis in the UK: an observational studyCarolynne J Vaizey, Peter R Gibson, Christopher M Black, et al.
Frontline Gastroenterology|August 15, 2023
Establishing key performance indicators for inflammatory bowel disease in the UKMohammed Nabil Quraishi, Elizabeth Dobson, Rachel Ainley, et al.
Therapeutic Advances in Chronic Disease|August 21, 2023
Two-year real-world outcome data from a single tertiary centre shows reduced ustekinumab persistence in a non-bio-naïve Crohn's disease cohort with penetrating disease, -ostomies and sarcopeniaSaskia Inniss, Konstantinos C Fragkos, Lisa Whitley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2018
Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103)Kathy D Miller, Anne O'Neill, William Gradishar, et al.
BMC Gastroenterology|August 12, 2014
METRIC (MREnterography or ulTRasound in Crohn's disease): a study protocol for a multicentre, non-randomised, single-arm, prospective comparison study of magnetic resonance enterography and small bowel ultrasound compared to a reference standard in those aged 16 and overStuart Taylor, Susan Mallett, Gauraang Bhatnagar, et al.
Gastrointestinal Endoscopy|April 17, 2018
Reliability among central readers in the evaluation of endoscopic disease activity in pouchitisMark A Samaan, Bo Shen, Mahmoud H Mosli, et al.
Pageof 5